Intra-Cellular Therapies ...

AI Score

0

Unlock

128.60
0.06 (0.05%)
At close: Feb 21, 2025, 3:59 PM
128.60
0.00%
After-hours: Feb 21, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Net Income -139.67M -256.26M -284.13M -227.01M -147.72M -155.13M -97.77M -116.43M -104.79M -30.69M -26.87M -16.59M
Depreciation & Amortization 528K 656K 533.36K 528.12K 477.12K 368.67K 213.87K 196.87K 139.63K 25.48K 23.25K 47.75K
Stock-Based Compensation 52.83M 43.01M 34.3M 24.11M 20.79M 17.4M 14.64M 14.7M 10.89M 3.84M 391.39K 295.11K
Other Working Capital 34.54M 11.16M 740.84K -7.53M 5.95M 12.16M -1.04M 1.27M 1.6M 4.6M -1.67M -1.67M
Other Non-Cash Items -8.31M 537K 178.53K 214.1K 194.21K -529.97M 1.06B 233.77K 182.6K 176.09K 391.39K -2.36M
Deferred Income Tax n/a n/a -4.08M -648.25K -1.13M 529.22M -1.06B 544.35K 712.67K 297.22K -391.39K n/a
Change in Working Capital -29.58M -58.14M -6.35M -27.28M -589.48K 19.94M 1.81M 9.49M -9.41M 3.54M 3.86M -2.65M
Operating Cash Flow -124.2M -270.19M -259.54M -230.07M -127.98M -118.17M -80.49M -91.26M -102.28M -22.81M -22.59M -18.9M
Capital Expenditures -269K -778K -325.74K -266.72K -700.39K -391.27K -723.43K -48.96K -860.6K -11.76K -33.26K -38.96K
Acquisitions n/a 127.59M -280.67M 480.03M -178.14M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -415.27M -759.21M -224.57M -755.63M -80.72M -271.16M -520.93M -395.76M -514.31M -103.6M n/a -12M
Sales Maturities Of Investments 521.08M 631.61M 505.24M 275.6M 258.86M 406.19M 428.93M 488.07M 153.39M 36.88M 1.5M 17.7M
Other Investing Acitivies n/a -127.59M 280.67M -480.03M 178.14M 135.03M -91.99M 92.31M -360.92M -66.72M 1.5M 5.7M
Investing Cash Flow 105.54M -128.37M 280.34M -480.3M 177.44M 134.64M -92.72M 92.26M -361.78M -66.73M 1.47M 5.66M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 31.08K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 17.81M 21.44M 11.52M 11.46M 3.24M 685.19K 285.16K 477.73K -103.27K -475.73K 40.53M 15.16M
Financial Cash Flow 17.81M 455.16M 11.52M 664.18M 3.24M 685.19K 162.36M 477.73K 449.89M 115.72M 40.63M 15.19M
Net Cash Flow -848K 56.6M 32.32M -46.19M 52.69M 17.16M -10.85M 1.48M -14.17M 26.17M 19.51M 1.95M
Free Cash Flow -124.47M -270.96M -259.87M -230.34M -128.68M -118.56M -81.22M -91.31M -103.14M -22.82M -22.62M -18.94M